China · Delayed Price · Currency is CNY Chongqing Zhifei Biological Products Company Description
Chongqing Zhifei Biological Products Co., Ltd., a biopharmaceutical company, engages in the research and development, production, sale, and distribution of vaccine and biological products in China.
The company offers recombinant COVID-19 vaccine; recombinant mycobacterium tuberculosis fusion protein products; group A and C meningococcal polysaccharide vaccine; ACYW135 meningococcal polysaccharide vaccine; Haemophilus Influenza type B conjugate vaccine; mycobacterium injection under the Vaccae brand; and meningococcal group A and C conjugate vaccine.
It also provides cold storage, refrigerated vehicles, and cold roll boxes; and customs clearance and registration of imported vaccines.
The company was founded in 2002 and is based in Chongqing, China.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6,292 |
| CEO | Lingfeng Jiang |
Contact Details
Address: Building T1, IFS Chongqing, 400020 China | |
| Phone | 86 23 8635 8685 |
| Website | zhifeishengwu.com |
Stock Details
| Ticker Symbol | 300122 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000V20 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Lingfeng Jiang | Vice Chairman of the Board and President |
| Zhijun Wang | Chief Engineer |
| Fei Qin | Vice President, Secretary of Board and Director |
| Yu Zhang | Vice president |
| Zhang Jing | Vice President |
| Jie Shao | Vice President |
| Hong Fan | Vice President |
| Cai Lian Jiang | Head of Accounting Department |
| Li Xie | Vice President |
| Xi Sheng Jiang | Vice President |